Skip to main content
ATRAptarGroup, Inc.Sell5.2·$124.28+3.04%
ATR · Concentration risk · 10-K extracted

AptarGroup (ATR) concentration risks

Updated

The most significant concentration AptarGroup discloses is single-source resins and rubber components, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: AptarGroup’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 2 disclosed concentrations

HIGH1
MEDIUM1
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHOutside partySupplier

single-source resins and rubber components

10-K Item 1A: 'we have historically sourced certain materials, especially some resins and rubber components for our Pharma segment, from a single source.'
SEC 10-K · filed Feb 2026
MEDIUMBuilt-inGeographic
49%

Europe

10-K Item 1: 'Europe is our largest region in terms of sales ... were approximately 49% and 49% of our consolidated sales, respectively.'
SEC 10-K · filed Feb 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-06-24

The company's concentration profile combines a supply-side dependency and a geographic tilt that operate on different risk channels. On the supplier side, certain materials — particularly some resins and rubber components for the Pharma segment — have historically been sourced from a single source. This is a high-share dependency by disclosed size, and its character reflects reliance on a specific vendor for inputs that are difficult to substitute quickly; a disruption at that source could affect production and margin in the Pharma segment more directly than a broadly diversified supply chain would allow. The geographic dimension is a moderate counterweight rather than an amplifier: Europe is the largest region by sales, representing approximately 49% of consolidated sales. By disclosed size this is a medium-share exposure, and its character is structural — it reflects where the company's customer base and manufacturing assets are positioned globally, not a reliance on any single European buyer or contract. Currency translation and regional economic cycles are the primary transmission mechanisms here, both of which tend to move gradually. Taken together, the more actionable of the two exposures is the single-source supplier risk in the Pharma segment, which is idiosyncratic and could affect results more abruptly. The European geographic exposure is diffuse and well-disclosed. Neither exposure points to a customer concentration risk layering on top.

For the engine’s reasoning on ATR’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Medical Instruments & Supplies

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
BLCOBausch + Lomb Corporation2002
BAXBaxter International Inc.1203
ATRAptarGroup, Inc.1102
BDXBecton, Dickinson and Company1102
ALGNAlign Technology, Inc.1001
AVTRAvantor, Inc.1001

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks ATR Concentration risk